Person

Nimrata Hunt

Executive Vice President, Idexx Laboratories

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$17.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 3, 2026IDXXSale1,758$634.57$1.1M
Feb 26, 2026IDXXSale2,693$661.54$1.8M
Nov 7, 2025IDXXSale1,465$703.73$1.0M
Nov 7, 2025IDXXSale1,468$704.87$1.0M
Nov 7, 2025IDXXSale1,378$705.54$972K
Nov 7, 2025IDXXSale5,114$702.20$3.6M
Aug 11, 2025IDXXSale1,200$656.53$788K
Aug 6, 2025IDXXSale1,218$630.69$768K
Aug 6, 2025IDXXSale2,907$630.91$1.8M
Aug 6, 2025IDXXSale3,018$629.87$1.9M
Aug 5, 2021IDXXSale538$703.00$378K
Nov 5, 2020IDXXSale2,098$470.08$986K
Aug 14, 2020IDXXSale2,676$377.50$1.0M
Aug 14, 2020IDXXSale100$377.51$38K

SEC reporting-owner ID (CIK) 1800619 · all filings on EDGAR